Covid-19 vaccine: Oxford trials show 70 per cent efficacy
Raising hopes for a rapid coronavirus vaccine roll-out, AstraZeneca and the University of Oxford on Monday announced that their experimental vaccine candidate, AZD1222, has shown 70 per cent effectiveness in preventing COVID-19, according to an interim analysis of the final data from clinical trials.
Other Pharmaceuticals Videos
AI in Pharma: How India's Drug Giants Are Betting Big on Artificial Intelligence
The brutal leadership lesson that shaped Dr. Reddy’s chief
We are discovery rich, but development poor
Budget 2026: India’s pharma leap, BioPharma SHAKTI gets ₹10K cr; 1,000 clinical trial sites planned
Corner Office Conversation: Nandini Piramal of Piramal Pharma & Arjun Juneja of Mankind Pharma
